Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Net Margin (2020 - 2025)

Historic Net Margin for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to 95.15%.

  • Biofrontera's Net Margin fell 322400.0% to 95.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.28%, marking a year-over-year decrease of 109800.0%. This contributed to the annual value of 47.58% for FY2024, which is 115000.0% up from last year.
  • Latest data reveals that Biofrontera reported Net Margin of 95.15% as of Q3 2025, which was down 322400.0% from 58.96% recorded in Q2 2025.
  • Biofrontera's 5-year Net Margin high stood at 57.03% for Q1 2022, and its period low was 369.45% during Q3 2021.
  • Over the past 5 years, Biofrontera's median Net Margin value was 62.53% (recorded in 2021), while the average stood at 74.61%.
  • Its Net Margin has fluctuated over the past 5 years, first crashed by -2776600bps in 2021, then surged by 3100800bps in 2022.
  • Quarter analysis of 5 years shows Biofrontera's Net Margin stood at 158.21% in 2021, then skyrocketed by 83bps to 27.45% in 2022, then skyrocketed by 221bps to 33.28% in 2023, then crashed by -133bps to 11.12% in 2024, then crashed by -756bps to 95.15% in 2025.
  • Its Net Margin stands at 95.15% for Q3 2025, versus 58.96% for Q2 2025 and 48.94% for Q1 2025.